Si-Pei Wu
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 4
- Cancer Cells and Metastasis 3
-
- Immunotherapy and Immune Responses 4
- Immune cells in cancer 2
- Co-authors
- Yi‐Long Wu (11 shared papers)Zhong‐Yi Dong (8 shared papers)Ri-Qiang Liao (4 shared papers)Wen‐Zhao Zhong (6 shared papers)Zhi Xie (7 shared papers)Xu‐Chao Zhang (6 shared papers)Jin‐Ji Yang (5 shared papers)Hai‐Yan Tu (7 shared papers)
- Journals
- Journal of Thoracic Oncology (4 papers)Heart (1 paper)Clinical Cancer Research (1 paper)Cancer Medicine (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Si-Pei Wu
23 papers receiving 1.5k citations
Si-Pei Wu's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 790
- Cancer Research 282
- Pulmonary and Respiratory Medicine 479
- Immunology 256
- Molecular Biology 468
Countries citing papers authored by Si-Pei Wu
This map shows the geographic impact of Si-Pei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si-Pei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si-Pei Wu more than expected).
Fields of papers citing papers by Si-Pei Wu
This network shows the impact of papers produced by Si-Pei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si-Pei Wu. The network helps show where Si-Pei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Si-Pei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma Hit paper breakdown → | 2016 | 758 |
| 2 | 2012 | 177 | |
| 3 | 2020 | 127 | |
| 4 | 2017 | 125 | |
| 5 | 2016 | 77 | |
| 6 | 2013 | 66 | |
| 7 | 2018 | 58 | |
| 8 | 2013 | 23 | |
| 9 | 2015 | 22 | |
| 10 | 2020 | 22 | |
| 11 | 2017 | 20 | |
| 12 | 2016 | 16 | |
| 13 | 2017 | 14 | |
| 14 | 2017 | 8 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 5 | |
| 17 | [Relation of advanced oxidation protein products with VEGF and TGF-β1 in colon cancer cells exposed to intermittent hypoxia]. | 2011 | 4 |
| 18 | 2017 | 4 | |
| 19 | 2011 | 1 | |
| 20 | 2017 | 1 |
About Si-Pei Wu
Si-Pei Wu is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Immune cells in cancer (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Oncology (790 citations), Cancer Research (282 citations), Pulmonary and Respiratory Medicine (479 citations), Immunology (256 citations) and Molecular Biology (468 citations). Si-Pei Wu has collaborated with scholars based in China, United States and India. Frequent co-authors include Yi‐Long Wu, Zhong‐Yi Dong, Ri-Qiang Liao, Wen‐Zhao Zhong, Zhi Xie, Xu‐Chao Zhang, Jin‐Ji Yang, Hai‐Yan Tu, Jian Su and Li‐Xu Yan. Their work appears in journals such as Journal of Thoracic Oncology, Heart, Clinical Cancer Research, Cancer Medicine and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.